Pancreatic cancer action network - Join us
Clinical Trial
Finder
Retrieving Trials
Retrieving Trials...

Back to Trial Search

Phase Ib/II Trial of the NANT Pancreatic Cancer Vaccine as Treatment for Patients with Pancreatic Cancer who have Progressed on or After Standard-Of-Care Therapy (QUILT-3.080)

Summary

The purpose of this phase Ib/II study is to evaluate the safety and efficacy of metronomic combination therapy in patients with pancreatic cancer who have progressed on or after previous Standard of Care (SoC) chemotherapy.

General Information

NCT#: NCT03586869
Study ID: QUILT-3.080
Trial Phase: Phase I/II

Trial Sponsor: NantKwest
Therapies Used in This Trial: Nab-paclitaxel, Fluorouracil, Oxaliplatin, Capecitabine, Stereotactic body radiotherapy (SBRT), Cyclophosphamide, Bevacizumab, Leucovorin, Aldoxorubicin, NANT Cancer Vaccine, ALT-803, Avelumab, ETBX-011, GI-4000 vaccine

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account?

Request an Account


  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account.
  • In order to view this information, you need to be signed in as a Health Care Provider.
  • In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
  • This information is restricted to validated Health Care Providers.

Eligibility



-------------------------------------------------------------------------------------------

  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
  • ------------------------------------------------------------------------------------------------------
  • In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information


Back to Trial Search